NFKB1 and Insulin resistance: The effect of M1 MVs on NF-κB activation and triggering of insulin resistance in adipocytes was further evaluated by treatment with BAY 11–7085, a reversible small molecule inhibitor of IκBα phosphorylation (Bay hereafter) [39].